코엔원

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medications during breastfeeding and pregnancy is a challenge for women suffering from the condition. There isn't much information on how long-term exposure to these drugs could affect the foetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders such as hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge that more high quality studies are required.

Risk/Benefit Analysis

Women who are pregnant and take ADHD medication need to consider the benefits of taking it versus the dangers for the foetus. Physicians do not have the data needed to give clear guidelines but they can provide information on the risks and benefits to help pregnant women make informed decisions.

A study published in Molecular Psychiatry concluded that women who took ADHD medication in early pregnancy were not at a greater risk of fetal malformations, or structural birth defects. Researchers used a vast population-based study of case-control to assess the risk of major structural birth defects in infants born to mothers who had taken stimulants during the early stages of pregnancy, and those who did not. Clinical geneticists and pediatric cardiologists reviewed the cases to ensure accurate case classification and to limit the chance of bias.

The study of the researchers was not without limitations. The researchers were not able to, in the first place, to separate the effects caused by the medication from the disorder. That limitation makes it difficult to know whether the limited associations observed in the groups that were exposed result from medication use or the confounding effect of comorbidities. In addition the researchers did not examine long-term offspring outcomes.

The study did reveal that infants whose mothers took adhd medication private prescription medication during pregnancy were at a slightly more risk of being admitted to the neonatal intensive care unit (NICU) than infants who whose mothers did not take any medication or had stopped their medications before or during pregnancy. The reason for this was central nervous system disorders. The higher risk of admission was not influenced by the stimulant medication that was used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher chance of having to have an emergency caesarean section or having one whose baby scored low on the Apgar scale (less than 7). These risks did not appear to be influenced by the kind of medication used during pregnancy.

Researchers suggest that the minor risk of using ADHD medications during early pregnancies can be offset by greater benefits to both mother and baby from continuing treatment for the woman's disorder. Physicians should discuss the issue with their patients and, if possible, help them develop strategies for improving their coping skills that may minimize the impact of her disorder on her daily life and relationships.

Medication Interactions

Many doctors are faced with the decision of whether to keep treatment or stop during pregnancy as more women are diagnosed with ADHD. Often, these decisions are made in the absence of solid and reliable evidence either way, so physicians must weigh what they know, the experiences of other doctors, and what the research says on the topic, along with their best judgment for each patient.

The issue of risk for infants can be extremely difficult. A lot of studies on this topic are based on observational data instead of controlled research and their findings are often contradictory. In addition, most studies limit their analysis to live births, which could underestimate the severity of teratogenic effects that could cause abortion or termination of the pregnancy. The study discussed in this journal club addresses these issues by examining data on both live and deceased births.

Conclusion Some studies have shown a positive correlation between ADHD medications and certain birth defects However, other studies haven't established a link. Most studies show an unintended, or slightly negative, effect. In the end an accurate risk-benefit analysis is required in every case.

It can be difficult, if not impossible for women suffering from ADHD to stop taking their medication. In a recent article in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can lead to increased depression, feelings of isolation and family conflict for those suffering from the disorder. Additionally, the loss of medication can interfere with the ability to do job-related tasks and drive safely, which are important aspects of a normal life for many people suffering from ADHD.

She suggests that women who aren't sure whether to continue taking the medication or stop it due to their pregnancy educate family members, coworkers and acquaintances about the condition, its impact on daily functioning and the benefits of keeping the current treatment plan. It can also help women feel more confident in her decision. Certain medications can be passed through the placenta. If a patient decides to stop taking her prescribe adhd medication medication while pregnant and breastfeeding, it is important to be aware that the drug could be passed on to her infant.

Birth Defects and Risk of

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) grows, so do concerns about what impact the medications could have on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this subject. Researchers used two massive data sets to study over 4.3 million pregnancies and determine if stimulant medication use increased the risk of birth defects. Although the risk overall remains low, the scientists discovered that the first-trimester exposure to ADHD medicines was associated with a slightly higher rate of specific heart defects, such as ventriculo-septal defect (VSD).

The researchers of the study found no connection between early medication use and other congenital anomalies, like facial clefting, or club foot. The results are in line with previous studies that have shown the existence different types of adhd medication a slight, but significant increase in the number of cardiac malformations among women who began taking ADHD medication prior to the time of the time of pregnancy. This risk increased during the latter stages of pregnancy when many women began to stop taking their medication.

Women who took ADHD medication in the first trimester of their pregnancies were also more likely to undergo a caesarean section, a low Apgar score following delivery, and a baby that required help breathing at birth. The researchers of the study were not able to remove bias in selection since they restricted the study to women who did not have any other medical conditions that might have contributed to the findings.

Researchers hope that their research will help doctors when they meet pregnant women. The researchers suggest that, while discussing the risks and benefits are important, the choice on whether to continue or stop medication should be made in light of the severity of each woman's ADHD symptoms and her requirements.

The authors also caution that even though stopping the medication is an option, it is not an option to consider due to the high incidence of depression and other mental health problems among women who are pregnant or who are recently post-partum. Additionally, the research suggests that women who decide to stop taking their medication are more likely to experience difficulties adapting to life without them after the birth of their baby.

Nursing

It can be a stressful experience becoming a mother. Women suffering from ADHD may face a lot of challenges when they must manage their symptoms, go to doctor appointments, prepare for the birth of their child and adjust to new routines. Therefore, many women decide to continue taking their ADHD medications throughout pregnancy.

The risk to a breastfeeding infant is not too high since the majority of stimulant medication is absorbed through breast milk at a low level. However, the amount of exposure to medication by the newborn can vary depending on the dosage, frequency it is administered, and at what time it is administered. In addition, various medications enter the baby’s system via the gastrointestinal tract or through breast milk. The impact of these medications on the health of a newborn is not fully comprehended.

Some doctors prescribing adhd medication (Read the Full Report) may decide to stop stimulant medication during a woman's pregnancy due to the absence of research. It is a difficult decision for the mother, who must weigh the advantages of continuing her medication against the potential risks to the fetus. In the meantime, until more information is available, doctors should ask all pregnant patients about their history of ADHD and whether they are taking or planning to take medication during the perinatal period.

Many studies have shown that women can continue to take their ADHD medication without risk during pregnancy and while breast-feeding. In response, a rising number of patients are choosing to do this. They have discovered after consulting with their doctors, that the benefits of continuing their current medication outweigh any potential risks.

Women with ADHD who are planning to nurse should seek advice from a specialist psychiatrist before becoming pregnant. They should discuss their medication with their prescriber as well as the pros and cons of continuing treatment. This includes non-pharmacological methods. Psychoeducation is also necessary to help pregnant women with ADHD recognize the signs and underlying disorder. They should also be informed about treatment options and strengthen strategies for coping. This should involve a multidisciplinary approach, which includes the GP, obstetricians and psychiatry. Pregnancy counseling should include a discussion of a treatment plan for the mother as well as the child, monitoring of indicators of deterioration, and, if needed adjustments to the medication regimen.